These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9684319)

  • 1. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum.
    Yang S; Benson SK; Du C; Healey MC
    J Parasitol; 2000 Aug; 86(4):884-7. PubMed ID: 10958482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone acetate immune suppression produces differing effects on Cryptosporidium muris oocyst production depending on when administered.
    Miller TA; Schaefer FW
    Vet Parasitol; 2007 Oct; 149(1-2):77-84. PubMed ID: 17719178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum.
    Miller TA; Schaefer FW
    Vet Parasitol; 2006 Oct; 141(1-2):66-83. PubMed ID: 16757117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts.
    Yang S; Healey MC
    J Parasitol; 1994 Apr; 80(2):338-42. PubMed ID: 8158484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptosporidium parvum--propagation of oocyst in neonatal calves.
    Ananthasubramanian M; Ananthan S
    Indian J Pathol Microbiol; 1997 Oct; 40(4):469-72. PubMed ID: 9444857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calves as a potential reservoir of Cryptosporidium parvum and Giardia sp.
    Bednarska M; Bajer A; Siński E
    Ann Agric Environ Med; 1998; 5(2):135-8. PubMed ID: 9860815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of patent infection in immunosuppressed C57Bl/6 mice with a single Cryptosporidium meleagridis oocyst.
    Huang K; Akiyoshi DE; Feng X; Tzipori S
    J Parasitol; 2003 Jun; 89(3):620-2. PubMed ID: 12880270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production.
    Miller TA; Schaefer FW
    Vet Parasitol; 2007 Nov; 149(3-4):147-57. PubMed ID: 17904293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice.
    Yang S; Healey MC; Du C
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):141-5. PubMed ID: 8731022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum.
    Novak SM; Sterling CR
    J Protozool; 1991; 38(6):103S-104S. PubMed ID: 1818125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Rasmussen KR; Healey MC; Cheng L; Yang S
    J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Cryptosporidium muris infection and reinfection in CF-1 mice.
    Miller TA; Schaefer FW
    Vet Parasitol; 2007 Mar; 144(3-4):208-21. PubMed ID: 17197093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvum.
    Chai JY; Guk SM; Han HK; Yun CK
    J Parasitol; 1999 Apr; 85(2):234-9. PubMed ID: 10219301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coccidial infection in immunosuppressed mice: prophylaxis and treatment with dehydroepiandrosterone.
    Khalifa AM; Ibrahim IR; el-Kerdany ED
    East Mediterr Health J; 2000; 6(5-6):908-18. PubMed ID: 12197348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.